
Environostics, Inc.
| Home | Diagnostic Test Development
| Contract Test
Development | Specialty Reagents | Contact
Information | About |
Description
- Environostics, Inc. is a privately-held R&D company ( Delaware)
developing rapid diagnostic tests/assays for clients. Environostics
produces prototype assays for clients, arranges for pre-clinical testing,
provides antibody and colloid reagents and develops lateral flow tests
using a novel platform.
Management
- Dr. Robert Bohannon is the founder of Environostics, Inc. Dr. Bohannon has been making rapid
diagnostic tests using lateral flow, PCR, EIA and other platforms for over
15 years. He has developed tests
for detecting biowarfare agents for industry and DoD; he also developed
the OraQuick HIV saliva test for Epitope (now OraSure Technologies) and
developed drug of abuse tests (Sure Screen) for MedTox Diagnostics. Dr. Bohannon holds patents on lateral
flow platforms (pending and issued), PCR technologies, molecular-antibody
hydrid detections methods, drug of abuse vaccines and other patents
pending. Dr. Bohannon also developed
the cold gold methodology and colloidal catalyst platforms.
Investors
- Environostics is currently self-funded. Investors/parties
interested in equity or acquisition should contact Dr. Bohannon directly.